Bristol-Myers Squibb Company
NYSE: BMY
$56.22
-$2.28 (-3.9%)
Closing Price on November 15, 2024
BMY Articles
Pharmaceuticals giant Bristol-Myers reported third-quarter results Thursday morning that beat analysts' expectations on both the top and bottom lines. So why did shares trade lower?
Published:
Health care is one sector that continues to draw a ton of fund manager interest, and with good reason. These five dividend-paying health care stocks are all favored by large-cap portfolio managers.
Published:
MyoKardia shares hit an all-time high early on Monday after it was announced that Bristol-Myers Squibb would be acquiring the company.
Published:
Tuesday's top analyst upgrades and downgrades included AbbVie, CSX, Dominion Energy, JPMorgan, NXP Semiconductors, ONEOK, Pfizer, Square, United Parcel Service and WPX Energy.
Published:
What may make sense now is for nervous investors to hunker down in safe dividend-paying stocks of companies with products that will not go out of demand, at least until the election is settled and we...
Published:
Tuesday’s top analyst upgrades and downgrades included Alibaba, Amazon.com, Apple, Carvana, Illumina, NextEra Energy, Nikola, Shake Shack, Teladoc Health and WPX Energy.
Published:
These five dividend-paying large-cap pharmaceutical stocks look like outstanding ideas for nervous investors looking for income and a degree of safety. They have come way in from their 52-week...
Published:
With the market showing the potential for some sizable rotation, the research team at BofA Securities has added Medtronic to the firm's US 1 List of top stocks to buy. It and three other US 1 health...
Published:
It is pretty clear that a defensive rotation already has started, and investors may want to consider rotating to these five top stocks from the overbought and very pricey tech sector.
Published:
This is a preview of a few of the most anticipated quarterly reports due this week, including CVS Health, Uber and Walt Disney.
Published:
Tuesday's top analyst upgrades and downgrades included ADM, Beyond Meat, Bristol-Myers, Carvana, CRISPR, FirstEnergy, Peloton, Shopify, Tesla, Uber and Visa.
Published:
The coming earnings data will be horrific, and the domestic and geopolitical scene is messy, so rotating to dividend-paying stocks that offer better upside and total return potential might be a very...
Published:
The April 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
The analysts at BofA Securities have made a big move by removing a high-profile company from the firm's well-respected US 1 list of stocks to buy. Some other picks look especially intriguing now.
Published:
Exelixis stock jumped early on Monday after the company, in conjunction with Bristol-Myers Squibb, announced positive late-stage results from its kidney cancer study.
Published: